Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|September 30, 2015
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9Ming Yuan, Xuefei Gao, Louisa S Chard, et al.Molecular Therapy Oncolytics|July 7, 2022
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibitionYijie Sun, Zhe Zhang, Chenglin Zhang, et al.Nature Chemical Biology|March 15, 2006
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4AMarie-Eve Bordeleau, Ayaka Mori, Monika Oberer, et al.Cells|November 13, 2020
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell CarcinomaZifang Zhang, Chunyang Zhang, Jinxin Miao, et al.Journal for Immunotherapy of Cancer|March 25, 2026
Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administrationNa Wang, Yijia He, Junzhi Yu, et al.Journal for Immunotherapy of Cancer|January 27, 2021
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancerGiulia Marelli, Louisa S Chard Dunmall, Ming Yuan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunityJames R Tysome, Xiaozhu Li, Shengdian Wang, et al.Molecular Therapy Oncolytics|May 26, 2022
Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R geneDujuan Cao, Qianqian Song, Junqi Li, et al.Oncoimmunology|June 3, 2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapyRenato B Baleeiro, Christian J Bouwens, Peng Liu, et al.Journal for Immunotherapy of Cancer|August 16, 2023
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancerRenato Brito Baleeiro, Peng Liu, Louisa S Chard Dunmall, et al.Pageof 5